Luminex Corporation (LMNX)
-NasdaqGS 18.87 
0.19(1.02%) 3:47PM EDT - Nasdaq Real Time Price
| Prev Close: | 18.68 |
|---|
| Open: | 18.75 |
|---|
| Bid: | 18.75 x 400 |
|---|
| Ask: | 18.77 x 200 |
|---|
| 1y Target Est: | 19.00 |
|---|
| Beta: | 0.61 |
|---|
| Next Earnings Date: | 29-Jul-13 |
|---|
| Day's Range: | 18.59 - 18.99 |
|---|
| 52wk Range: | 15.39 - 25.79 |
|---|
| Volume: | 180,281 |
|---|
| Avg Vol (3m): | 185,675 |
|---|
| Market Cap: | 784.75M |
|---|
| P/E (ttm): | 120.26 |
|---|
| EPS (ttm): | 0.16 |
|---|
| Div & Yield: | N/A (N/A) |
|---|
The broker you select will become the default broker for Trade Now
Quotes delayed, except where indicated otherwise. Currency in USD.
Headlines
- Luminex's CEO Presents at UBS Global Healthcare Conference (Transcript)at Seeking Alpha(Tue, May 21)
- In Insider Trading, Tesla Motors Sees a Sale While MoSys CEO Buys SharesMinyanville(Tue, May 21)
- Monday 5/20 Insider Buying Report: LMNX, GFFat Forbes(Mon, May 20)
- LUMINEX CORP Files SEC form 8-K, Submission of Matters to a Vote of Security HoldersEDGAR Online(Mon, May 20)
- Genomic Health Director Buys More Than 52K Shares and 4 Insider Trades to Noteat Wall St. Cheat Sheet(Fri, May 17)
- Finding Value in the Medical Products and Device Spaces: An Experienced Portfolio Manager Discusses Investing in Overlooked Health Care AreasWall Street Transcript(Fri, May 17)
- Luminex Director Buys More Than 54K Shares and 4 Insider Trades to Noteat Wall St. Cheat Sheet(Thu, May 9)
- SPX Corp Part-Owner Buys More Than 196K Shares and 4 Insider Trades to Noteat Wall St. Cheat Sheet(Wed, May 8)
- Luminex Corporation To Present At Upcoming Investment ConferencesPR Newswire(Tue, May 7)
- Opko Health CEO Buys More Than 27K Shares and 4 Insider Trades to Noteat Wall St. Cheat Sheet(Tue, May 7)
- Top Buys by Directors: Loewenbaum II's $421.6K Bet on LMNXat Forbes(Mon, May 6)
- Monday 5/6 Insider Buying Report: LMNX, NEMat Forbes(Mon, May 6)
- LUMINEX CORP FinancialsEDGAR Online Financials(Sat, May 4)
- Luminex Beats 1Q Earnings Est.Zacks(Wed, May 1)
- Bullish Two Hundred Day Moving Average Cross - LMNXat TheStreet(Tue, Apr 30)
Key Statistics
| Forward P/E (1 yr): | 33.50 |
|---|
| P/S (ttm): | 3.75 |
|---|
| Ex-Dividend Date: | N/A |
|---|
Analysts
| Annual EPS Est
(Dec-13)
: | 0.31 |
|---|
| Quarterly EPS Est
(Jun-13)
: | 0.10 |
|---|
| Mean Recommendation*: | 2.8 |
|---|
| PEG Ratio (5 yr expected): | 1.13 |
|---|
Business Summary
Luminex Corporation engages in the development, manufacture, and sale of proprietary biological testing technologies and products for the life sciences and diagnostic industries.
View More